Development and characterization of proteasome inhibitors

Methods in Enzymology

Volumn 399, Issue , 2005, Pages 585-609

  Bo Kim, Kyung ^a   Fonseca, Fabiana N ^a   Crews, Craig M ^a  

^a YALE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BENZYLOXYCARBONYLLEUCYLLEUCYLLEUCINAL; BORTEZOMIB; CALPASTATIN; EPONEMYCIN; EPOPROMYCIN A; EPOPROMYCIN B; EPOXOMICIN; MG 115; PROTEASOME INHIBITOR; TMC 86A; TMC 86B; TMC 89; TMC 96; UNCLASSIFIED DRUG; YU 101; YU 102;

ANTINEOPLASTIC ACTIVITY; CATALYSIS; DRUG SYNTHESIS; ENZYME ACTIVITY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; KINETICS; PHARMACOPHORE; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN FUNCTION; PURIFICATION; REVIEW; STRUCTURE ANALYSIS;

CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DRUG DESIGN; KINETICS; OLIGOPEPTIDES; PROTEASE INHIBITORS; PROTEASOME ENDOPEPTIDASE COMPLEX; STEREOISOMERISM; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 28844484584     PISSN: 00766879     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S0076-6879(05)99039-3     Document Type: Review

References (45)

1. Adams J. Development of the proteasome inhibitor PS-341 Oncologist 7 2002 9 16
2. Adams J., Behnke M., Chen S., Cruickshank A.A., Dick L.R., Grenier L., Klunder J.M., Ma Y.T., Plamondon L., and Stein R.L. Potent and selective inhibitors of the proteasome: Dipeptidyl boronic acids Bioorg. Med. Chem. Lett. 8 1998 333 338
3. Albericio F., and Carpino L.A. Coupling reagents and activation Methods Enzymol. 289 1997 104 126
4. Bennacer B., Rivalle C., and Grierson D. A new route for the total synthesis of 6,7-dihydroeponemycin Eur. J. Org. Chem. 23 2003 4569 4574
5. Bogyo M., McMaster J.S., Gaczynska M., Tortorella D., Goldberg A.L., and Ploegh H. Covalent modification of the active site threonine of proteasomal beta subunits and the Escherichia coli homolog HslV by a new class of inhibitors Proc. Natl. Acad. Sci. USA 94 1997 6629 6634
6. Bogyo M., Shin S., McMaster J.S., and Ploegh H.L. Substrate binding and sequence preference of the proteasome revealed by active-site-directed affinity probes Chem. Biol. 5 1998 307 320
7. Carpino L.A. 1-Hydroxy-7-azabenzotriazole. An efficient peptide coupling additive J. Am. Chem. Soc. 115 1993 4397 4398
8. Casp C.B., She J.X., and McCormack W.T. Genes of the LMP/TAP cluster are associated with the human autoimmune disease vitiligo Genes Immun. 4 2003 492 499
9. Corey E.J., and Widiger G.N. J. Org. Chem. 40 1975 2975 2976
10. Dobler M.R. Total synthesis of (+)-epopromycin B and its analogues - studies on the inhibition of cellulose biosynthesis Tetrahedron Lett. 42 2001 215 218
11. Elofsson M., Splittgerber U., Myung J., Mohan R., and Crews C.M. Towards subunit-specific proteasome inhibitors: Synthesis and evaluation of peptide α′,β′-epoxyketones Chem. Biol. 6 1999 811 822
12. Fenteany G., Standaert R.F., Lane W.S., Choi S., Corey E.J., and Schreiber S.L. Inhibition of proteasome activities and subunit-specific amino-terminal threonine modification by lactacystin Science 268 1995 726 731
13. Fields G.B. "Methods in Enzymology." 1997 Academic Press New York
14. Figueiredo-Pereira M.E., Banik N., and Wilk S. Comparison of the effect of calpain inhibitors on two extralysosomal proteinases: The multicatalytic proteinase complex and m-calpain J. Neurochem. 62 1994 1989 1994
15. Fruh K., Gossen M., Wang K., Bujard H., Peterson P.A., and Yang Y. Displacement of housekeeping proteasome subunits by MHC-encoded LMPs: A newly discovered mechanism for modulating the multicatalytic proteinase complex EMBO J. 13 1994 3236 3244
16. Groll M., Kim K.B., Kairies N., Huber R., and Crews C.M. Crystal structure of epoxomicin: 20s proteasome reveals a molecular basis for selectivity of α′,β′-epoxyketone proteasome inhibitors J. Am. Chem. Soc. 122 2000 1237 1238
17. Hanada M., Sugawara K., Kaneta K., Toda S., Nishiyama Y., Tomita K., Yamamoto H., Konishi M., and Oki T. Epoxomicin, a new antitumor agent of microbial origin J. Antibiot. (Tokyo) 45 1992 1746 1752
18. Hoshi H., Ohnuma T., Aburaki S., Konishi M., and Oki T. A total synthesis of 6,7-dihydroeponemycin and determination of stereochemistry of the epoxide ring Tetrahedron Lett. 34 1993 1047 1050
19. Iqbal M., Chatterjee S., Kauer J.C., Mallamo J.P., Messina P.A., Reiboldt A., and Siman R. Potent a-ketocarbonyl and boronic ester derived inhibitors of proteasome Bioorg. Med. Chem. Lett. 6 1996 287 290
20. Iwabuchi Y., Sugihara T., Esumi T., and Hatakeyama S. An enantio- and stereocontrolled route to epopromycin B via cinchona alkaloid-catalyzed Baylis-Hillman reaction Tetrahedron Lett. 42 2001 7867 7871
21. Kim K.B., and Crews C.M. Natural product and synthetic proteasome inhibitors J. Adams "Cancer Drug Discovery and Development: Proteasome Inhibitors in Cancer Therapy" 2003 Humana Press Inc. Totowa, NJ 47 63
22. Kim K.B., Myung J., Sin N., and Crews C.M. Proteasome inhibition by the natural products epoxomicin and dihydroeponemycin: Insights into specificity and potency Bioorg. Med. Chem. Lett. 9 1999 3335 3340
23. Kisselev A.F., and Goldberg A.L. Proteasome inhibitors: From research tools to drug candidates Chem. Biol. 8 2001 739 758
24. Kloetzel P.M. Antigen processing by the proteasome Nat. Rev. Mol. Cell Biol. 2 2001 179 187
25. Koguchi Y., Kohno J., Nishio M., Takahashi K., Okuda T., Ohnuki T., and Komatsubara S. TMC-95A, B, C, and D, novel proteasome inhibitors produced by Apiospora montagnei Sacc. TC 1093. Taxonomy, production, isolation, and biological activities J. Antibiot. (Tokyo) 53 2000 105 109
26. Koguchi Y., Kohno J., Suzuki S., Nishio M., Takahashi K., Ohnuki T., and Komatsubara S. TMC-86A, B and TMC-96, new proteasome inhibitors from Streptomyces sp. TC 1084 and Saccharothrix sp. TC 1094. I. Taxonomy, fermentation, isolation, and biological activities J. Antibiot. (Tokyo) 52 1999 1069 1076
27. Koguchi Y., Kohno J., Suzuki S., Nishio M., Takahashi K., Ohnuki T., and Komatsubara S. TMC-86A, B and TMC-96, new proteasome inhibitors from Streptomyces sp. TC 1084 and Saccharothrix sp. TC 1094. II. Physico-chemical properties and structure determination J. Antibiot (Tokyo) 53 2000 63 65
28. Koguchi Y., Nishio M., Suzuki S., Takahashi K., Ohnuki T., and Komatsubara S. TMC-89A and B, new proteasome inhibitors from Streptomyces sp. TC 1087 J. Antibiot. (Tokyo) 53 2000 967 972
29. Lloyd-Williams P., Albericio F., and Giralt E. "Chemical Approaches to the Synthesis of Peptides and Proteins." 1997 CRC Press Boca Raton, Florida
30. Meng L., Kwok B.H., Sin N., and Crews C.M. Eponemycin exerts its antitumor effect through the inhibition of proteasome function Cancer Res. 59 1999 2798 2801
31. Meng L., Mohan R., Kwok B.H., Elofsson M., Sin N., and Crews C.M. Epoxomicin, a potent and selective proteasome inhibitor, exhibits in vivo antiinflammatory activity Proc. Natl. Acad. Sci. USA 96 1999 10403 10408
32. Myung J., Kim K.B., and Crews C.M. The ubiquitin-proteasome pathway and proteasome inhibitors Med. Res. Rev. 21 2001 245 273
33. Myung J., Kim K.B., Lindsten K., Dantuma N.P., and Crews C.M. Lack of proteasome active site allostery as revealed by subunit-specific inhibitors Mol. Cell. 7 2001 411 420
34. Nahm S., and Weinreb S.M. N-methoxy-N-methylamides as effective acylating agents Tetrahedron Lett. 22 1981 3815 3818
35. Nam S., Smith D.M., and Dou Q.P. Ester bond-containing tea polyphenols potently inhibit proteasome activity in vitro and in vivo J. Biol. Chem. 276 2001 13322 13330
36. Orlowski M. The multicatalytic proteinase complex, a major extralysosomal proteolytic system Biochemistry 29 1990 10289 10297
37. Rock K.L., and Goldberg A.L. Degradation of cell proteins and the generation of MHC class I-presented peptides Annu. Rev. Immunol. 17 1999 739 779
38. Rock K.L., Gramm C., Rothstein L., Clark K., Stein R., Dick L., Hwang D., and Goldberg A.L. Inhibitors of the proteasome block the degradation of most cell proteins and the generation of peptides presented on MHC class I molecules Cell 78 1994 761 771
39. Schmidt U., and Schmidt U. The total synthesis of eponemycin Synthesis 3 1994 300 304
40. Sekizawa R., Momose I., Kinoshita N., Naganawa H., Hamada M., Muraoka Y., Iinuma H., and Takeuchi T. Isolation and structural determination of phepropeptins A, B, C, and D, new proteasome inhibitors, produced by Streptomyces sp J. Antibiot. (Tokyo) 54 2001 874 881
41. Sin N., Kim K.B., Elofsson M., Meng L., Auth H., Kwok B.H., and Crews C.M. Total synthesis of the potent proteasome inhibitor epoxomicin: A useful tool for understanding proteasome biology Bioorg. Med. Chem. Lett. 9 1999 2283 2288
42. Sin N., Meng L., Auth H., and Crews C.M. Eponemycin analogues: Syntheses and use as probes of angiogenesis Bioorg. Med. Chem. 6 1998 1209 1217
43. Sugawara K., Hatori M., Nishiyama Y., Tomita K., Kamei H., Konishi M., and Oki T. Eponemycin, a new antibiotic active against B16 melanoma. I. Production, isolation, structure and biological activity J. Antibiot. (Tokyo) 43 1990 8 18
44. Tsuchiya K., Kobayashi S., Nishikiori T., Nakagawa T., and Tatsuta K. Epopromycins, novel cell wall synthesis inhibitors of plant protoplast produced by Streptomyces sp. NK04000 J. Antibiot. (Tokyo) 50 1997 261 263
45. Vinitsky A., Cardozo C., Sepp-Lorenzino L., Michaud C., and Orlowski M. Inhibition of the proteolytic activity of the multicatalytic proteinase complex (proteasome) by substrate-related peptidyl aldehydes J. Biol. Chem. 269 1994 29860 29866